0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine

Buy Now

Second Generation Cell and Gene-Based Therapies - Biological Advances, Clinical Outcomes and Strategies for Capitalisation (Hardcover) Loot Price: R3,352
Discovery Miles 33 520
Second Generation Cell and Gene-Based Therapies - Biological Advances, Clinical Outcomes and Strategies for Capitalisation...

Second Generation Cell and Gene-Based Therapies - Biological Advances, Clinical Outcomes and Strategies for Capitalisation (Hardcover)

Alain Vertes, Nathan J. Dowden, Devyn Smith, Nasib Qureshi

 (sign in to rate)
Loot Price R3,352 Discovery Miles 33 520 | Repayment Terms: R314 pm x 12*

Bookmark and Share

Expected to ship within 12 - 17 working days

Donate to Against Period Poverty

Second Generation Cell and Gene-Based Therapies: Biological Advances, Clinical Outcomes, and Strategies for Capitalisation serves as the only volume to the market to bridge basic science, clinical therapy, technology development, and business in the field of cellular therapy/cytotherapy. After more than two decades of painstaking fundamental research, the concept of therapeutic cells (stem cells, genes, etc.), beyond the concept of vaccines, is reaching clinical trial, with mounting confidence in the safety and efficacy of these products. Nonetheless, numerous incremental technical advances remain to be achieved. Thus, this volume highlights the possible R&D paths, which will ultimately facilitate clinical delivery of cutting edge curative products. The next waves of innovation are reviewed in depth for hematopoietic stem cells, mesenchymal stem cells, tissue engineering, CAR-T cells, and cells of the immune system, as well as for enabling technologies such as gene and genome editing. Additionally, deep dives in product fundamentals, history of science, pathobiology of diseases, scientific and technological bases, and financing and technology adoption constraints are taken to unravel what will shape the cytotherapy industry to the horizon 2025 and beyond. The outcome is not simply a scientific book, but a global perspective on the nascent field combining science, business, and strategic fundamentals.

General

Imprint: Academic Press Inc
Country of origin: United States
Release date: February 2020
First published: 2020
Editors: Alain Vertes • Nathan J. Dowden • Devyn Smith • Nasib Qureshi
Dimensions: 229 x 152mm (L x W)
Format: Hardcover
Pages: 846
ISBN-13: 978-0-12-812034-7
Categories: Books > Medicine > Clinical & internal medicine > General
Books > Medicine > Nursing & ancillary services > Biomedical engineering > General
LSN: 0-12-812034-7
Barcode: 9780128120347

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners